Search Results

Filter
  • 1-10 of  538 results for ""Chalcone""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Novel furan chalcone modulates PHD-2 induction to impart antineoplastic effect in mammary gland carcinoma.

  • Authors : Rastogi S; Department of Pharmaceutical Sciences, School of Biomedical and Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University (A Central University), Lucknow, Uttar Pradesh, India.; Ansari MN

Subjects: Chalcones*/Chalcones*/Chalcones*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Chalcone*

  • Source: Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2024 Apr; Vol. 38 (4), pp. e23679.Publisher: Wiley Country of Publication: United States NLM ID: 9717231 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Safflower yellow and its main component hydroxysafflor yellow A alleviate hyperleptinemia in diet-induced obesity mice through a dual inhibition of the GIP-GIPR signaling axis.

  • Authors : Lyu X; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.; Yan K

Subjects: Obesity*/Obesity*/Obesity*/drug therapy ; Chalcone*/Chalcone*/Chalcone*/analogs & derivatives ; Chalcone*/Chalcone*/Chalcone*/pharmacology

  • Source: Phytotherapy research : PTR [Phytother Res] 2024 Oct; Vol. 38 (10), pp. 4940-4956. Date of Electronic Publication: 2023 Mar 21.Publisher: Wiley Country of Publication: England NLM ID: 8904486 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Anti-inflammatory, antiosteoporotic, and bone protective effect of hydroxysafflor yellow A against glucocorticoid-induced osteoporosis in rats.

  • Authors : Kuai J; Department of Spine, Affiliated Jianhu Hospital of Xinglin College, Nantong University, Yancheng, China.; Zheng J

Subjects: Osteoporosis*/Osteoporosis*/Osteoporosis*/chemically induced ; Osteoporosis*/Osteoporosis*/Osteoporosis*/prevention & control ; Osteoporosis*/Osteoporosis*/Osteoporosis*/metabolism

  • Source: Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2024 Sep; Vol. 38 (9), pp. e23797.Publisher: Wiley Country of Publication: United States NLM ID: 9717231 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure-activity relationship.

  • Authors : Gao F; State Key Laboratory of Biobased Material and Green Papermaking (LBMP), Qilu University of Technology (Shandong Academy of Sciences), Jinan, China.; Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China.

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Chalcone*/Chalcone*/Chalcone*/pharmacology

  • Source: Medicinal research reviews [Med Res Rev] 2020 Sep; Vol. 40 (5), pp. 2049-2084. Date of Electronic Publication: 2020 Jun 11.Publisher: Wiley Country of Publication: United States NLM ID: 8103150 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

trans-Chalcone inhibits high-fat diet-induced disturbances in FXR/SREBP-1c/FAS and FXR/Smad-3 pathways in the kidney of rats.

  • Authors : Alipour MR; Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.; Jeddi S

Subjects: Chalcone* ; Chalcones*/Chalcones*/Chalcones*/pharmacology ; Chalcones*/Chalcones*/Chalcones*/therapeutic use

  • Source: Journal of food biochemistry [J Food Biochem] 2020 Nov; Vol. 44 (11), pp. e13476. Date of Electronic Publication: 2020 Sep 17.Publisher: Wiley Country of Publication: United States NLM ID: 7706045 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

A chalcone derivative, 1m-6, exhibits atheroprotective effects by increasing cholesterol efflux and reducing inflammation-induced endothelial dysfunction.

  • Authors : Chen LW; Division of Cardiology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.; Tsai MC

Subjects: Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/prevention & control ; Chalcone*/Chalcone*/Chalcone*/pharmacology

  • Source: British journal of pharmacology [Br J Pharmacol] 2020 Dec; Vol. 177 (23), pp. 5375-5392. Date of Electronic Publication: 2020 Jul 20.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The importance of natural chalcones in ischemic organ damage: Comprehensive and bioinformatic analysis review.

  • Authors : Sayed AM; Biochemistry Laboratory, Chemistry Department, Faculty of Science, Assiut University, Assiut, Egypt.; Gohar OM

Subjects: Chalcone* ; Chalcones*/Chalcones*/Chalcones*/chemistry ; Chalcones*/Chalcones*/Chalcones*/pharmacology

  • Source: Journal of food biochemistry [J Food Biochem] 2022 Oct; Vol. 46 (10), pp. e14320. Date of Electronic Publication: 2022 Jul 20.Publisher: Wiley Country of Publication: United States NLM ID: 7706045 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Isoliquiritin treatment of osteoporosis by promoting osteogenic differentiation and autophagy of bone marrow mesenchymal stem cells.

  • Authors : Su Z; Department of Prosthodontics, School and Hospital of Stomatology, Guangdong Engineering Research Center of Oral Restoration and Reconstruction & Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China.; Chen D

Subjects: Osteoporosis*/Osteoporosis*/Osteoporosis*/drug therapy ; Mesenchymal Stem Cells* ; Glucosides*

  • Source: Phytotherapy research : PTR [Phytother Res] 2024 Jan; Vol. 38 (1), pp. 214-230. Date of Electronic Publication: 2023 Oct 19.Publisher: Wiley Country of Publication: England NLM ID: 8904486 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Pharmacokinetic characteristics of hydroxysafflor yellow A in normal and diabetic cardiomyopathy mice.

  • Authors : Yao R; Department of Traditional Chinese Medicine, The First Affiliated Hospital, The Air Force Medical University, Xi'an, China.; Department of Chinese Materia Medica and Natural Medicines, School of Pharmacy, The Air Force Medical University, Xi'an, China.

Subjects: Antioxidants*/Antioxidants*/Antioxidants*/analysis ; Antioxidants*/Antioxidants*/Antioxidants*/chemistry ; Antioxidants*/Antioxidants*/Antioxidants*/pharmacokinetics

  • Source: Biomedical chromatography : BMC [Biomed Chromatogr] 2021 Oct; Vol. 35 (10), pp. e5173. Date of Electronic Publication: 2021 May 28.Publisher: Wiley Country of Publication: England NLM ID: 8610241 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

MS-based metabolite analysis of two licorice chalcones in mice plasma, bile, feces, and urine after oral administration.

  • Authors : Wu J; Department of Pharmaceutical Analysis, Jiangsu College of Nursing, Huai'an, China.; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.

Subjects: Chalcone/Chalcone/Chalcone/*analogs & derivatives ; Chalcones/Chalcones/Chalcones/*analysis ; Chromatography, Liquid/Chromatography, Liquid/Chromatography, Liquid/*methods

  • Source: Biomedical chromatography : BMC [Biomed Chromatogr] 2021 Mar; Vol. 35 (3), pp. e4998. Date of Electronic Publication: 2020 Oct 29.Publisher: Wiley Country of Publication: England NLM ID: 8610241 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  538 results for ""Chalcone""